Generated by Meeveem AI
"A global leader in biological reagents and tools that accelerate life science research breakthroughs"
Abcam develops and distributes validated antibodies, proteins, assays, and reagents enabling life science researchers worldwide to progress faster. Serving 750,000 researchers across 130 countries, the company provides tools to study critical pathways in cancer, neurological disorders, infectious diseases, and metabolic conditions. With over 110,000 products backed by validation data and expert support, Abcam helps researchers advance from hypothesis to breakthrough. The company solves a fundamental challenge: finding antibodies with the sensitivity and consistency needed for reproducible results. By embedding rigorous validation and collaborating with the research community, Abcam ensures scientists access reliable biological tools.
1800
Team Members
1998
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where every researcher has access to the validated, reliable biological tools they need to accelerate breakthroughs in disease treatment, diagnostics, and understanding of fundamental biology.
At Abcam, our mission is to help accelerate the next breakthrough in drug discovery, diagnostics, and basic research.